This was revealed through a study that is to be presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, that would be held in Chicago, IL, on June this year.
For patients with stage III colon cancer, whereby the cancer has spread to nearby lymph nodes or tissues, 5-year survival rates range from around 53 to 89 percent.
The new study, however, suggests that regular consumption of tree nuts may lower the likelihood of cancer recurrence following treatment for stage III colon cancer and improve patient survival.
A number of studies have documented the potential of Cashew nuts, hazelnuts, walnuts, almonds, and pecans to humans health as they are capable of reducing the probability of colon cancer recurrence after an individual being treated for the disease.
Another research published in 2014, associated tree nut intake with reduced risk of obesity and metabolic syndrome, while other study has associated tree nut consumption with better heart he
This study was lead by author Dr. Temidayo Fadelu, of the Dana Farber Cancer Institute in Boston, MA, and colleagues to set out investigations whether overall nut intake or tree nut consumption alone might benefit patients with colon cancer.
0 comments:
Post a Comment